The role of cancer stem cells in relapse of solid tumors

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 4, 2012, Pages 1528-1541

  Yu, Yang ^a   Ramena, Grace ^a   Elble, Randolph C ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cancer relapse; Cancer stem cells; Glioblastoma; Melanoma; Review

Indexed keywords

ABAMECTIN; BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY DNA; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETOPOSIDE; FIBRONECTIN; HERMES ANTIGEN; INTERLEUKIN 8; KISSPEPTIN; KISSPEPTIN 1; MASPIN; METFORMIN; MULTIDRUG RESISTANCE PROTEIN 1; NESTIN; NIGERICIN; NOTCH RECEPTOR; PACLITAXEL; PROTEIN P53; SALINOMYCIN; SONIC HEDGEHOG PROTEIN; TEMOZOLOMIDE; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT PROTEIN;

BLADDER CANCER; BREAST CANCER; BREAST EPITHELIUM; CANCER RECURRENCE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL TYPE; CHEMORADIOTHERAPY; DNA DAMAGE; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; IONIZING RADIATION; KIDNEY CARCINOMA; LUNG METASTASIS; MELANOMA; MESENCHYME CELL; NEURAL STEM CELL; NONHUMAN; OSTEOSARCOMA; PANCREAS CANCER; PRIMARY TUMOR; PROSTATE CANCER; RADIOSENSITIVITY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SOLID TUMOR; THERAPY RESISTANCE; TISSUE DIFFERENTIATION; TRIPLE NEGATIVE BREAST CANCER; TUMOR ASSOCIATED LEUKOCYTE; WNT SIGNALING PATHWAY; WOUND HEALING; NEOPLASM; PATHOLOGY; RECURRENT DISEASE;

HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; RECURRENCE;

EID: 84860873820     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. Fred H Hochberg and Amy Pruitt: Assumptions in the radiotherapy of glioblastoma. Neurology 30(9), 907-911 (1980) (Pubitemid 10059239)
2. http://foodforbreastcancer.com/news/follow-up-Afterbreast-cancer-should- Take-into-Account-risk-of-relapse)
3. http://news.cancerconnect.com/recurrent-prostate-cancer/)
4. http://news.cancerconnect.com/recurrentosteosarcoma/#-edn1)
5. http://www.physorg.com/news/2011-01-Treatment-relapsebladder-cancer- patients.html)
6. Stephen R Sullivan, Der-Zen Liu, David W Mathes and Frank F Isik. Head and Neck Malignant Melanoma: Local Recurrence Rate Following Wide Local Excision and Immediate Reconstruction. Ann Plast Surg 4 (2011)
7. Dong-Seol Lee, Donald E White, Rachel Hurst, Steven A Rosenberg and James C Yang. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy. Cancer J Sci Am 4(2), 86-93 (1998) (Pubitemid 29090712)
8. Rowan T Chlebowski, George L Blackburn, Cynthia A Thomson, Daniel W Nixon, Alice Shapiro, Katherine M Hoy, Marc T Goodman, Armando E Giuliano, Njeri Karanja, Philomena McAndrew, Clifford Hudis, John Butler, Douglas Merkel, Alan Kristal, Bette Caan, Richard Michaelson, Vincent Vinciguerra, Salvatore Del Prete, Marion Winkler, Rayna Hall, Michael Simon, Barbara L Winters and Robert M Elashoff: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study (WINS). J Natl Cancer Inst Vol. 98, 1767-1776 (2006) (Pubitemid 46017928)
9. Tsvee Lapidot, Christian Sirard, Josef Vormoor, Barbara Murdoch, Trang Hoang, Julio Caceres-Cortes, Mark Minden, Bruce Paterson, Michael A Caligiuri and John E Dick: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994) (Pubitemid 24067706)
10. Muhammad Al-Hajj, Max S Wicha, Adalberto Benito-Hernandez, Sean J Morrison and Michael F Clarke: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 100(7), 3983-3988 (2003) (Pubitemid 36418143)
11. John E Dick: Stem cell concepts renew cancer research. Blood 112, 4793-4807 (2008)
12. Akos Fábián, Mark Barok, Gyorgy Vereb, and Janos Szöllosi: Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 75(1), 67-74 (2009)
13. Akanksha Singh, and Jeffrey Settleman. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29(34), 4741-4751 (2010)
14. Chao Chen, Yan Wei, Michael Hummel, Thomas K Hoffmann, Manfred Gross, Andreas M Kaufmann and Albers E Albers. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 6(1), e16466 (2011)
15. Seema Sethi, Jill Macoska, Wei Chen and Fazlul H Sarkar. Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis. Am J Transl Res 3(1), 90-99 (2010)
16. Bin Bao, Zhiwei Wang, Shadan Ali, Dejuan Kong, Yiwei Li, Aamir Ahmad, Sanjeev Banerjee, Asfar S Azmi, Lucio Miele, and Fazlul H Sarkar. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett April 2 (2011)
17. Adriana Eramo, Lucia Ricci-Vitiani, Ann Zeuner, Roberto Pallini, Francesco Lotti, Giovanni Sette, Pilozzi, Luigi Maria Larocca, Cesare Peschle and Ruggero De Maria: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13(7), 1238-1241 (2006) (Pubitemid 43905604)
18. Isabelle Germano, Victoria Swiss and Patrizia Casaccia. Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link? Neuropharmacology 58(6), 903-910 (2010)
19. Christine E Horak, Jong Heun Lee, Jean-Claude Marshall, Martin Shreeve and Patricia S Steeg. The role of metastasis suppressor genes in metastatic dormancy. APMIS 116(7-8), 586-501(2008)
20. Jean-Claude Marshall, Joshua Collins, Natascia Marino and Patricia Steeg. The Nm23-H1 metastasis suppressor as a translational target. Eur J Cancer 46(7), 1278-1282 (2010)
21. Jaron Lockett, Shuping Yin, Xiaohua Li, Yonghong Meng and Shijie Sheng. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 97(4), 651-660 (2006)
22. Wen Liu, Megumi Iiizumi-Gairani, Hiroshi Okuda, Aya Kobayashi, Misako Watabe, Sudha K Pai, Puspa Raj Pandey, Fei Xing, Koji Fukuda, Vishnu Modur, Shigeru Hirota, Kazuyuki Suzuki, Toshimi Chiba, Masaki Endo, Tamotsu Sugai, and Kounosuke Watabe. KAI1 is engaged in NDRG1-mediated metastasis suppression through ATF3-NFkappaB complex in human prostate cancer. J Biol Chem Mar 21 (2011)
23. Megumi Iiizumi, Wen Liu, Sudha K Pai, Eiji Furuta and Kounosuke Watabe. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 1786(2), 87-04 (2008)
24. Benjamin H Beck and Danny R Welch. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells. Eur J Cancer 46(7), 1283-1289 (2010)
25. David G DeNardo, Jairo B Barreto, Pauline Andreu, Lesley Vasquez, David Tawfik, Nikita Kolhatkar and Lisa M Coussens. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2), 91-102 (2009)
26. Katie DeClerck and Randolph C Elble. The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy. Front Biosci 15, 213-225 (2010)
27. Dominique Bonnet and John E Dick: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3, 730-737 (1997) (Pubitemid 27298715)
28. Catherine A O'Brien, Aaron Pollett, Steven Gallinger and John E Dick: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445 (7123), 106-110 (2007) (Pubitemid 46067310)
29. Brent A Reynolds and Samuel Weiss: Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175(1), 1-13 (1996) (Pubitemid 26150042)
30. Lara Lacerda, Lajos Pusztai and Wendy A Woodward: The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approaches. Drug Resist Updat 13(4-5), 99-108 (2010)
31. Michael Dean. ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 14(1), 3-9 (2009)
32. Natasha Y Frank, Armen Margaryan, Ying Huang, Tobias Schatton, Ana Maria Waaga-Gasser, Martin Gasser, Mohamed H Sayegh, Wolfgang Sadee and Markus H Frank: ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 65(10), 4320-4333 (2005) (Pubitemid 40775671)
33. Ryohei Katayama, Sumie Koike, Shigeo Sato, Yoshikazu Sugimoto, Takashi Tsuruo and Naoya Fujita: Dofequidar fumarate sensitizes cancer stem-like side population cells to chemotherapeutic drugs by inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci 100(11), 2060-2068 (2009)
34. Sheng Zhou, John D Schuetz, Kevin D Bunting, Anne-Marie Colapietro, Janardhan Sampath, John J Morris, Irina Lagutina, Gerard Grosveld, Mitsujiro Osawa, Hiromitsu Nakauchi, and Brain P Sorrentino: The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7(9), 1028-1034 (2001) (Pubitemid 32937383)
35. Charlotte Hirschmann-Jax, Aaron E Foster, Gerald G Wulf, Jed G Nuchtern, Thomas W Jax, Ulrich Gobel, Margaret A Goodell and Malcolm K Brenner. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A. 101(39),14228-14233 (2004) (Pubitemid 39305058)
36. Lubna Patrawala, Tammy Calhoun, Robin Schneider-Broussard, Jianjun Zhou, Kent Claypool and Dean G Tang. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Res 65(14), 6207-6219 (2005) (Pubitemid 40994406)
37. Mehdy Ratajczak, Maciej Tarnowski, Magdalena Staniszewska, T Sroczynski and Bridget Banach: Mechanisms of cancer metastasis: involvement of cancer stem cells? Minerva Med 101(3), 179-191 (2010)
38. Shujun Liu and Max S Wicha. Targeting breast cancer stem cells. J Clin Oncol 28(25), 4006-4012 (2010)
39. Ilya V Ulasov, Suvobroto Nandi, Mahua Dey, Adam M Sonabend and Maciej S Lesniak: Inhibition of Sonic Hedgehog and Notch Pathways Enhances Sensitivity of CD 133(+) Glioma Stem Cells to Temozolomide Therapy. Mol Med 17(1-2), 103-112 (2011)
40. Sandra A O'Toole, Alexander Swarbrick and Robert L Sutherland. The Hedgehog signalling pathway as a therapeutic target in early breast cancer development. Expert Opin Ther Targets 13(9), 1095-1103 (2009)
41. Gillian Farnie and Robert Clarke. Mammary stem cells and breast cancer-role of Notch signalling. Stem Cell Rev 3 (2), 169-175 (2007) (Pubitemid 350129719)
42. Pietro Rizzo, Clodia Osipo, Kyle Foreman, Todd Golde, Benjamin Osborne and Lucio Miele. Rational targeting of Notch signaling in cancer. Oncogene 27(38), 5124-5131 (2008)
43. Hasan Korkaya, Ariel Paulson, Flora Iovino and Max S Wicha. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27(47), 6120-6130 (2008)
44. Sonia Mohinta, Hailong Wu, Priyasri Chaurasia and Kounosuke Watabe. Wnt pathway and breast cancer. Front Biosci 12, 4020-4033 (2007)
45. Naoko Takebe, Pamela J Harris, Ronald Q Warren and Percy Ivy. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Onco 8(2), 97-106 (2011)
46. Mark Shackleton, Francois Vaillant, Kaylene J Simpson, John Stingl, Gordon K Smyth, Marie-Liesse Asselin-Labat, Li Wu, Geoffrey J Lindeman and Jane E Visvader. Generation of a functional mammary gland from a single stem cell. Nature 439, 84-88 (2006) (Pubitemid 43053633)
47. Jong In Yook, Xiao-Yan Li, Ichiro Ota, Casey Hu, Hyun Sil Kim, Nam Hee Kim, Young Cha So, Joo Kyung Ryu, Yoon Jung Choi, Jin Kim, Eric R Fearon and Stephen J Weiss. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Bio 8(12), 1398-1406 (2006) (Pubitemid 44835115)
48. Maralice Conacci-Sorrell, Inbal Simcha, Tamar Ben-Yedidia, Janna Blechman, Pierre Savagner and Avri Ben-Ze'ev. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 163, 847-857 (2003) (Pubitemid 37517891)
49. Louise R Howe, Osamu Watanabe, James Leonard and Anthony M Brown. Twist is up-regulated in response to Wnt1 and inhibits mouse mammary cell differentiation. Cancer Res 63(8), 1906-2013 (2003)
50. Theresa A DiMeo, Kristen Anderson, Pushkar Phadke, Chang Fan, Charles M Perou, Steven Naber and Charlotte Kuperwasser. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelialmesenchymal transition in basal-like breast cancer. Cancer Res 69(13), 5364-5373 (2009)
51. Wendy A Woodward, Mercy S Chen, Fariba Behbod, Maria P Alfaro, Thomas A Buchholz and Jeffrey M Rosen: WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 104(2), 618-623 (2007) (Pubitemid 46123074)
52. Sean J Morrison and Judith Kimble: Asymmetric and symmetric stem-cell divisions in development and cancer. Nature 441(7097), 1068-1074 (2006) (Pubitemid 43990718)
53. Angelo Cicalese, Giuseppina Bonizzi, Cristina E Pasi, Mario Faretta, Simona Ronzoni, Barbara Giulini, Cathrin Brisken, Saverio Minucci, Pier Paolo Di Fiore and Pier Giuseppe Pelicci: The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138(6), 1083-1095 (2009)
54. Sendurai A Mani, Wenjun Guo, Mai-Jing Liao, Elinor Ng Eaton, Ayyakkannu Ayyanan, Alicia Y Zhou, Mary Brooks, Ferenc Reinhard, Cheng Zhang, Michail Shipitsin, Lauren L Campbell, Kornelia Polyak, Cathrin Brisken, Jing Yang and Robert A Weinberg: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008) (Pubitemid 351636299)
55. Gabriela Dontu, Wissam M Abdallah, Jessica M Foley, Kyle W Jackson, Michael F Clarke, Mari J Kawamura and Max S Wicha: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17(10), 1253-1270 (2003) (Pubitemid 36583168)
56. Suling Liu, Gabriela Dontu, Ilia D Mantle, Shivani Patel, Nam-Shik Ahn, Kyle W Jackson, Prerna Suri and Max S Wicha: Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66(12), 6063-6071 (2006)
57. Therese Sørlie, Charles M Perou, Robert Tibshirani, Turid Aas, Stephanie Geisler, Hilde Johnsen, Trevor Hastie, Michael B Eisen, Rijn Matt van de, Stefanie S Jeffrey, Thor Thorsen, Hanne Quist, John C Matese, Patrick O Brown, David Botstein, Per Eystein Lønning and Anne-Lise Børresen-Dale: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98(19), 10869-10874 (2001) (Pubitemid 32878711)
58. Charles M Perou, Therese Sørlie, Michael B Eisen, Rijn Matt van de, Stefanie S Jeffrey, Christian A Rees, Jonathan R Pollack, Douglas T Ross, Hilde Johnsen, Lars A Akslen, Oystein Fluge, Alexander Pergamenschikov, Cherly Williams, Shirley X Zhu, Per E Lønning, Anne-Lise Børresen-Dale, Patrick O Brown and David Botstein : Molecular portraits of human breast tumours. Nature 406(6797), 747-752 (2000)
59. David Sarrió, Socorro Maria Rodriguez-Pinilla, David Hardisson, Cano Amparo, Moreno-Bueno Ema, and Palacios Jose: Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 68(4), 989-997 (2008) (Pubitemid 351272216)
60. Bryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, Michael Z Gilcrease, Savitri Krishnamurthy, Ju-Seog Lee, Jane Fridlyand, Ayseul Sahin, Roshan Agarwal, Corwin Joy, Wenbin Liu, David Stivers, Keith Baggerly, Mark Carey, Ana Lluch, Carlos Monteagudo, Xiapin He, Victor Weigman, Chen Fan, Juan Palazzo, Gabriel N Hortobagyi, Laura K Nolden, Nicholas J Wang, Vicente Valero, Joe W Gray, Charles M Perou, Gordon B Mills: Characterization of a naturally occurring breast cancer subset enriched in epithelial-To-mesenchymal transition and stem cell characteristics. Cancer Res 69(10), 4116-4124 (2009)
61. Aleix Prat, Joel S Parker, Olga Karginova, Cheng Fan, Chad Livasy, Jason I Herschkowitz, Xiaping He and Charles M Perou: Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12(5), R68 (2010)
62. Joseph H Taube, Jason I Herschkowitz, Kakajan Komurov, Alicia Y Zhou, Supriya Gupta, Jing Yang, Kimberly Hartwell, Tamer T Onder, Piyush B Gupta, Kurt W Evans, Brett G Hollier, Prahlad T Ram, Eric S Lander, Jeffrey M Rosen, Robert A Weinberg and Sendurai A Mani: Core epithelial-To-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci U S A 107(35), 15449-15454 (2010)
63. Maximilian Diehn, Robert W Cho, Neethan A Lobo, Tomer Kalisky, Mary J Dorie, Angela N Kulp, Dalong Qian, Jessica S Lam, Laurie E Ailles, Manzhi Wong, Benzion Joshua, Michael J Kaplan, Irene Wapnir, Frederick M Dirbas, George Somlo, Carlos Garberoglio, Benjamin Paz, Jeannie Shen, Sean K Lau, Stephen R Quake, Brown J Martin, Irving L Weissman and Michael F Clarke: Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239), 780-783 (2009)
64. Tiffany M Phillips, William H McBride and Frank Pajonk: The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98(24), 1777-1785 (2006) (Pubitemid 46017929)
65. Philip J Coates, Appleyard M Virginia, Karen Murray, Caroline Ackland, Jeffrey Gardner, Dorothy C Brown, Douglas J Adamson, Lee B Jordan, Colin A Purdie, Alastair J Munro, Eric G Wright, John A Dewar and Alastair M Thompson: Differential contextual responses of normal human breast epithelium to ionizing radiation in a mouse xenograft model. Cancer Res 70(23), 9808-9815 (2010)
66. Jean Paul Thiery: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15(6), 740-746 (2003) (Pubitemid 37487967)
67. Tony Blick, Honor Hugo, Edwin Widodo, Mark Waltham, Cletus Pinto, Sendurai A Mani, Robert A Weinberg, Richard M Neve, Marc E Lenburg and Erik W Thompson: Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer. J Mammary Gland Biol Neoplasia 15(2) 235-252 (2010)
68. Jean Paul Thiery and Jonathan P Sleeman: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2), 131-142 (2006) (Pubitemid 43278296)
69. Kornelia Polyak and Robert A Weinberg: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9(4), 265-273 (2009)
70. Jean Paul Thiery: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2(6), 442-454 (2002)
71. Susan E Moody, Denise Perez, Tien-Chi Pan, Christopher J Sarkisian, Carla P Portocarrero, Christopher J Sterner, Kathleen L Notorfrancesco, Robert D Cardiff and Lewis A Chodosh: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8(3), 197-209 (2005) (Pubitemid 41317591)
72. Bram De Craene and Geert Berx: Snail in the frame of malignant tumor recurrence. Breast Cancer Research 8, 105(2006)
73. Archana Dhasarathy, Masahiro Kajita and Paul A Wade: The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-Alpha. Mol Endocrinol 21(12), 2907-2918 (2007) (Pubitemid 350223504)
74. Jing Yang, Sendurai A Mani, Joana Liu Donaher, Sridhar Ramaswamy, Raphael A Itzykson, Christophe Come, Pierre Savagner, Inna Gitelman, Andrea Richardson and Robert A Weinberg: Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117(7), 927-939 (2004) (Pubitemid 38798858)
75. Piyush B Gupta, Tamer T Onder and Guozhi Jiang: Identification of selective inhibitors of cancer stem cells by high-Throughput screening. Cell 138(4), 645-659 (2009)
76. Heather A Hirsch, Dimitrios Iliopoulos, Philip N Tsichlis and Kevin Struhl: Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission. Cancer Res 69(19), 7507-7511 (2009)
77. Xiaoxian Li, Michael T Lewis, Jian Huang, Carolina Gutierrez, Cent K Osborne, Meng-Fen Wu, Susan G Hilsenbeck, Anne Pavlick, Xiaomei Zhang, Gary C Chamness, Helen Wong, Jeffrey Rosen and Jenny C Chang: Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100(9), 672-679 (2008)
78. Chad J Creighton, Xiaoxian Li, Melissa Landis, Dixon J Michael, Veronique M Neumeister, Ashley Sjolund, David L Rimm, Helen Wong, Angel Rodriguez, Jason I Herschkowitz, Cheng Fan, Xiaomei Zhang, Xiaping He, Anne Pavlick, Carolina Gutierrez, Lorna Renshaw, Alexa Larionov, Dana Faratian, Susan G Hilsenbeck, Charles M Perou, Michael T Lewis, Jeffrey M Rosen and Jenny C Chang: Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 106(33), 13820-13825 (2009)
79. Emmanuelle Charafe-Jauffret, Charafe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, Francois Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum and Max S Wicha. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69(4), 1302-1313 (2009)
80. Patrick C Hermann, Stephan L Huber, Tanja Herrler, Alexandra Aicher, Joachim W Ellwart, Markus Guba, Christiane J Bruns and Christopher Heeschen. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3), 313-323 (2007) (Pubitemid 47355323)
81. Nancy Gavert, Alessia Vivanti, John Hazin, Thomas Brabletz and Avri Ben-Ze'ev. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol Cancer Res 9(1), 14-24 (2011)
82. Adriana Eramo, Lucia Ricci-Vitiani, Ann Zeuner, Roberto Pallini, Francesco Lotti, Giovanni Sette, Emanuela Pilozzi, Luigi Maria Larocca, Cesare Peschle and Ruggero De Maria: Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 13(7), 1238-1241 (2006) (Pubitemid 43905604)
83. Sheila K Singh, Cynthia Hawkins, Ian D Clarke and A Jeremy. Squire, jane Bayani, Takuichiro Hide, R.Mark Henkelman, Michael D. Cusimano and Peter B Dirks: Identification of human brain tumour initiating cells. Nature 432(7015), 396-401 (2004)
84. Roberto Pallini, Lucia Ricci-Vitiani, Nicola Montano, Cristiana Mollinari, Mauro Biffoni, Tonia Cenci, Francesco Pierconti, Maurizio Martini, Ruggero De Maria and Luigi Maria Larocca: Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer 117(1), 162-174 (2011)
85. Shideng Bao, Qiulian Wu, Roger E McLendon, Yueling Hao, Qing Shi, Anita B Hjelmeland, Mark W Dewhirst, Darell D Bigner and Jeremy N Rich: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120), 756-760 (2006) (Pubitemid 44949604)
86. http://healthforworld.blogspot.com/2008/11/skincancer.html)
87. http://seer.cancer.gov/statfacts/html/melan.html)
88. Susan E Zabierowski and Meenhard Herlyn: Learning the ABCs of melanoma-initiating cells. Cancer Cell 13 (3), 185-187 (2008) (Pubitemid 351318377)
89. Alberto Fusi, Uta Reichelt, Antonia Busse, Sebastian Ochsenreither, Anika Rietz, Markus Maisel and Ulrich Keilholz: Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. J Invest Dermatol 131(2), 487-494 (2011)
90. Piyush B Gupta, Charlotte Kuperwasser, Jean-Philippe Brunet, Sridhar Ramaswamy, Wen-Lin Kuo, Joe W Gray, Stephen P Naber, and Robert A Weinberg: The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37(10), 1047-1054 (2005) (Pubitemid 41486656)
91. Elsa Quintana, Mark Shackleton, Michael S Sabel, Douglas R Fullen, Timothy M Johnson and Sean J Morrison: Efficient tumour formation by single human melanoma cells. Nature 456(7222), 593-598 (2008)
92. Elsa Quintana, Mark Shackleton, Hannah R Foster, Douglas R Fullen, Michael S Sabel, Timothy M Johnson and Sean J Morrison: Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 18(5), 510-523 (2010)
93. Matthew A Held, David P Curley, David Dankort, Martin McMahon, Viswanathan Muthusamy and Marcus W Bosenberg: Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 70(1), 388-397 (2010)
94. Alexander Roesch, Mizuho Fukunaga-Kalabis, Elizabeth C Schmidt, Schmidt E Zabierowski, Patricia A Brafford, Adina Vultur, Devraj Basu, Phyllis Gimotty, Thomas Vogt and Meenhard Herlyn: A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141(4), 583-594 (2010)
95. Ryan Morrison, Stephen M Schleicher, Yunguang Sun, Kenneth J Niermann, Sungjune Kim, Daniel E Spratt, Christine H Chung and Bo Lu: Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis. J Oncol 2011, 941876 (2011)
96. Helmut Ponta, Larry Sherman and Peter A Herrlich: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4(1), 33-45 (2003) (Pubitemid 36077255)
97. Samuel Godar, Tan A Ince, George W Bell, David Feldser, Joana Liu Donaher, Jonas Bergh, Anne Liu, Kevin Miu, Randolph S Watnick, Ferenc Reinhardt, Sandra S McAllister, Tyler Jacks and Robert A Weinberg: Growthinhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 134(1), 62-73 (2008) (Pubitemid 351905743)
98. Lilly Y Bourguignon, Christina C Spevak, Gabriel Wong, Weiliang Xia and Eli Gilad: Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-Apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 284(39), 26533-26546 (2009)
99. Germana Rappa, Oystein Fodstad and Aurelio Lorico. The stem cell-Associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 26(12), 3008-1307 (2008)
100. Lloyd M Smith, Anastasia Nesterova, Michael C Ryan, Steve Duniho, Mario Jonas, Monique Anderson, Roger F Zabinski, May Kung Sutherland, Hans-Peter Gerber, Orden KL Van, Paul A Moore, Steven M Ruben and Paul J Carter: CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers. Br J Cancer 99(1), 100-109 (2008) (Pubitemid 351920235)
101. Naotsugu Haraguchi, Hideshi Ishii, Koshi Mimori, Fumiaki Tanaka, Masahisa Ohkuma, Ho Min Kim, Hirofumi Akita, Daisuke Takiuchi, Hisanori Hatano, Hiroaki Nagano, Graham F Barnard, Yuichiro Doki and Masaki Mori: CD13 is a therapeutic target in human liver cancer stem cells. J Clin Invest 120(9), 3326-3339 (2010)
102. Miaorong She and Xilin Chen: Targeting Signal Pathways active in Cancer Stem Cells to Overcome Drug Resistance. Zhongguo Fei Ai Za Zhi 12(1), 3-7 (2009)
103. Hannah Harrison, Gillian Farnie, Sacha J Howell, Rebecca E Rock, Spyros Stylianou, Keith R Brennan, Nigel J Bundred and Robert B Clarke: Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 70(2), 709-718 (2010)
104. Pedro J Real and Adolfo A Ferrando: NOTCH inhibition and glucocorticoid therapy in T-cell acute lymphoblastic leukemia. Leukemia 23(8), 1374-1377 (2009)
105. Charlotta Lindvall, Wen Bu, Bart O Williams and Yi Li: Wnt signaling, stem cells, and the cellular origin of breast cancer. Stem Cell Rev 3(2), 157-168 (2007) (Pubitemid 350129718)
106. Madhuri Kakarala, Dean E Brenner, Hasan Korkaya, Connie Cheng, Karim Tazi, Christophe Ginestier, Suling Liu, Gabriela Dontu and Max S Wicha: Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Res Treat 122(3), 777-785 (2010)
107. Chandra P Prasad, Gayatri Rath, Sandeep Mathur, Dinesh Bhatnagar and Ranju Ralhan: Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling. Chem Biol Interact 181(2), 263-271 (2009)
108. Atul Goel and Bharat B Aggarwal: Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 62(7), 919-930 (2010)
109. Sarvjeet Singh and Ashok Khar: Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem 6(3), 259-270 (2006) (Pubitemid 43796643)
110. Guido Shoba, David Joy, Thangam Joseph, Mudassir Majeed, Ramaswamy Rajendran and PS Srinivas: Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64(4), 353-356 (1998) (Pubitemid 28234275)
111. Rjinder K Bhardwaj, Hartmut Glaeser, Laurent Becquemont, Ulrich Klotz, Suresh K Gupta and Martin F Fromm: Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302(2), 645-650 (2002) (Pubitemid 34787231)
112. Pornngarm Limtrakul, Wanida Chearwae, Suneet Shukla, Chada Phisalphong, Suresh V Ambudkar: Modulation of function of three ABC drug transporters, Pglycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol Cell Biochem 296(1-2), 85-95 (2007)
113. Yanyan Li, Tao Zhang, Hasan Korkaya, Suling Liu, Hsiu-Fang Lee, Bryan Newman, Yanke Yu, Shawn G Clouthier, Steven J Schwartz, Max S Wicha and Duxin Sun: Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells. Clin Cancer Res 16(9), 2580-2590 (2010)
114. Akil A Merchant and William Matsui: Targeting Hedgehog-A cancer stem cell pathway. Clin Cancer Res 16(12), 3130-3140 (2010)
115. Frederic Varnat, Arnaud Duquet, Monica Malerba, Marie Zbinden, Christophe Mas, Pascal Gervaz and Altaba Ariel Ruizi: Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion. EMBO Mol Med 1(6-7), 338-351 (2009)
116. Michael K Cooper, Jeffrey A Porter, Keith E Young and Philip A Beachy: Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280(5369), 1603-1607 (1998) (Pubitemid 28277705)
117. Jianjun Zhang, Massoud Garrossian, Dale Gardner, Arash Garrossian, Young-Tae Chang, Yun Kyung Kim and Cheng-Wei Chang: Synthesis and anticancer activity studies of cyclopamine derivatives. Bioorg Med Chem Lett 18(4), 1359-1363 (2008) (Pubitemid 351226541)
118. Benjamin Z Stanton and Lee F Peng: Small-molecule modulators of the Sonic Hedgehog signaling pathway. Mol Biosyst 6(1), 44-54 (2010)
119. Christophe Ginestier, Suling Liu, Mark E Diebel, Hasan Korkaya, Ming Luo, Marty Brown, Julien Wicinski, Olivier Cabaud, Emmanuelle Charafe-Jauffret, Daniel Birnbaum, Jun-Lin Guan, Gabriela Dontu and Max S Wicha: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120(2), 485-497 (2010)
120. Dimitrios Iliopoulos, Heather A Hirsch, Guixiang Wang and Kevin Struhl: Inducible formation of breast cancer stem cells and their dynamic equilibrium with nonstem cancer cells via IL6 secretion. Proc Natl Acad Sci U S A 108(4), 1397-1402 (2011)
121. Efstathios Kastritis, Andreas Charidimou, Andreas Varkaris and Meletios A Dimopoulos: Targeted therapies in multiple myeloma. Target Oncol 4(1), 23-36 (2009)
122. Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, Ming Tan, Franscisco J Esteva, Aysegul A Sahin, Kristine S Klos, Ping Li, Brett P Monia, Nina T Nguyen, Gabriel N Hortobagyi, Mien-Chie Hung and Dihua Yu: PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance inpatients. Cancer Cell 6(2), 117-127 (2004) (Pubitemid 39485684)